The use of prescribed opioid analgesics & the risk of serious infections
- PMID: 29896976
- PMCID: PMC6060396
- DOI: 10.2217/fmb-2018-0101
The use of prescribed opioid analgesics & the risk of serious infections
Keywords: immunosuppression; opioid analgesics; serious infections.
Conflict of interest statement
This work was funded in part by the National Institutes of Health (R03 AG042981 and R01 AG043471). AD Wiese has no financial disclosures or conflicts of interest to report. CG Grijalva has received consulting fees from Pfizer and Merck and received research support from Sanofi-Pasteur, Campbell Alliance, the Centers for Disease Control and Prevention, National Institutes of Health, The Food and Drug Administration, and the Agency for Healthcare Research and Quality. The authors have no other relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript apart from those disclosed.
No writing assistance was utilized in the production of this manuscript.
References
-
- Okie S. A flood of opioids, a rising tide of deaths. NEJM. 2010;363(21):1981–1985. - PubMed
-
- Jani M, Dixon WG. Opioids are not just an American problem. BMJ (Clinical Res. Ed.) 2017;359:j5514. - PubMed
-
- Dowell D, Haegerich TM, Chou R. CDC Guideline for prescribing opioids for chronic pain – United States, 2016. MMWR Recomm. Rep. 2016;65(1):1–49. - PubMed
-
- Benyamin R, Trescot AM, Datta S, et al. Opioid complications and side effects. Pain Physician. 2008;11(Suppl. 2):S105–S120. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical